Skip Navigation

Our partners

In order to carry out our work programme, the EPDA relies on partnerships with external organisations. However, to ensure our independence, we do not accept donations that are dependent on policies set by others. The EPDA Board and Team are careful to ensure that any funds received do not influence the organisation’s vision, strategic goals or other projects.

We would like to thank all our partners and supporters for their continued interest and partnership. We look forward to working closely with you all in the future.

Our funding partners

The following funding partners are companies and organisations of high standing and reputation, all of whom agree with the EPDA’s overall strategic direction and help support the integrity of our organisation. Our partnerships with these companies are established on shared interest, transparency, trust and mutual benefit, and do not imply the EPDA’s endorsement of any corporation (or their products or services).

Diamond partners

Gold partners

Silver partners


Code of practice for funding partners

The EPDA has developed its own code of practice to maintain its independence and transparency. Specifically, the EPDA has a code with regards to its:

Relationship with industrial and other potential partners

  • Relationships between the EPDA and its industrial (and any other) partners are based on equal partnership. Both sides will work together on policy development and practical initiatives in the interests of all EPDA member organisations and the EPDA's overall strategic direction
  • Successful partnerships are those where both partners gain by making the effort to understand the internal culture and external pressures of the other.


  • Funding will be declined if its application compromises the EPDA’s independence in any way
  • As an independent organisation, the EPDA relies on no conflict of interest, and insists on total transparency with the funder as well as the exchange of agreed and signed contracts
  • The EPDA favours the use of funding consortia of two or more companies to meet its strategic direction
  • Details of the EPDA’s funding are included here and within its Financial reports
  • The EPDA requires its funders to adhere to relevant company, national and international codes of conduct, including notifying their support for the EPDA on their websites.

Product endorsement

  • The EPDA’s name must not be used to imply approval or endorsement of any of the funders’ products
  • The EPDA encourages research into new treatments and the better application of existing therapies. It does not endorse the use of individual treatments over others
  • The EPDA supports the proper licensing of medicines.

Note: In addition to the EPDA’s own code of practice, the EPDA is also guided by the European Medical Agencies (EMA) and the European Federation of Pharmaceutical Industry Associations (EFPIA) codes of practice. For further information on these two codes, visit EMA and EFPIA.

Becoming a funding partner

There are a number of options available for external organisations and individuals to become a committed EPDA funding partner.

Why become an EPDA partner?

By becoming an EPDA partner, your company will:

  • help enable the EPDA to carry out its strategic goals on behalf of people with Parkinson’s and their families
  • engage with a long-standing, highly reputable and well-respected not-for-profit organisation (the EPDA)
  • enhance your company’s visibility at a European level
  • demonstrate your company’s commitment to corporate social responsibility
  • help the fight against the effects of Parkinson’s disease, which have an impact across nearly every cultural, social and economic boundary.

For more specific information about how your funding will help people with Parkinson's, please download the EPDA brochure.

The 2019 partnership options

There are three main tiers to choose from when considering becoming an EPDA funding partner: diamond, gold or silver. Potential partners are able to choose the amount they pay within each tier. Without your generous help, the EPDA would not exist, so we thank you very much for considering to help us.






Starting at €20,000

Starting at €35,000

Starting at €50,000

Acknowledgment of your sponsorship within the EPDA annual report and other relevant publications and materials




Your company name and link appearing on the partners section of the EPDA website




Invitations to EPDA events, including European Parliament activities, press conferences and annual Members' Meetings




Receive EPDA endorsement for your company’s projects/materials (if approved by our Expert Review Panel)*




The opportunity to contribute medical information within the About Parkinson’s section of the EPDA website




At least one seat at the Treatment Industry Group Meeting table (see below)




The possibility of engaging the EPDA to work as advisers on your company’s educational projects/communications*




An invitation to contribute to the development of EPDA projects/activities




Discounted Parkinson's Life sponsored articles (normally €3,500 per article)

10% discount

20% discount

40% discount

A profile and video (if desired) of your company on the partners section of the EPDA website (content to be agreed with the EPDA)



Your company’s news shared prominently via the EPDA’s social media platforms and news section (if desired)



Quarterly update on EPDA activities (if desired)



Other opportunities to be discussed




*Note: depending on the level of work needed to be done by the EPDA, there may be additional costs to be covered. Please contact us if you have any questions.

Note on diamond partners

We currently has one diamond partner: Boston Scientific. Diamond partner companies have been extremely supportive to us for many years and recognise the benefits of working closely with the only European Parkinson’s umbrella organisation.

We thank these companies for their generous support over the years, and invite others to become diamond partners so that we can do even more valuable work on behalf of the Parkinson’s community.

Explanation of Treatment Industry Group Meeting

Since the EPDA’s formation in 1992, we have worked successfully in partnership with the industry. Without this support, we would not be in a position to carry out the majority of our work programme.

To develop our partnerships further, we launched the Treatment Industry Group Meeting forum in 2009. All EPDA funding partners are invited to these collaborative roundtable meetings (usually bi-annual), which have developed into a valuable and trusted way of working and have led to greater awareness and understanding for all concerned.

The exclusive Treatment Industry Group meetings are among the most important dates in our calendar, and they ensure that all parties work together effectively towards our common goal. For more information about these meetings, please contact

Other opportunities for collaboration

The EPDA will happily discuss other projects and activities not mentioned above (i.e., for those companies not comfortable spending €20,000). Please contact for more information.

Our agency partners

The following agencies are our trusted friends and supporters who have, in their own unique ways, enabled us to make great strides in recent years towards realising our mission. Your support is, as ever, greatly appreciated.

Other partners

Back to top